Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.28B |
| 2 |
Apple
AAPL
|
+$1.23B |
| 3 |
Broadcom
AVGO
|
+$682M |
| 4 |
Amazon
AMZN
|
+$629M |
| 5 |
Palo Alto Networks
PANW
|
+$595M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$247M |
| 2 |
Cadence Design Systems
CDNS
|
+$160M |
| 3 |
O'Reilly Automotive
ORLY
|
+$155M |
| 4 |
Synopsys
SNPS
|
+$145M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$135M |
Sector Composition
| 1 | Technology | 28.26% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Sprinklr
CXM
$1.88B
| $21.6M | ﹤0.01% |
1,562,328
+955,758
| +158% | +$13.2M |
|
1802
indie Semiconductor
INDI
$770M
| $21.6M | ﹤0.01% |
2,298,411
+552,229
| +32% | +$5.19M |
|
1803
Zeta Global
ZETA
$4.84B
| $21.6M | ﹤0.01% |
2,525,221
+411,752
| +19% | +$3.52M |
|
1804
S&T Bancorp
STBA
$1.5B
| $21.5M | ﹤0.01% |
792,206
+26,076
| +3% | +$709K |
|
1805
Sweetgreen
SG
$1B
| $21.5M | ﹤0.01% |
1,674,872
+193,996
| +13% | +$2.49M |
|
1806
Aehr Test Systems
AEHR
$792M
| $21.4M | ﹤0.01% |
519,003
+265,373
| +105% | +$10.9M |
|
1807
Travere Therapeutics
TVTX
$2.09B
| $21.4M | ﹤0.01% |
1,391,756
+175,182
| +14% | +$2.69M |
|
1808
Astec Industries
ASTE
$1.06B
| $21.3M | ﹤0.01% |
469,780
+10,265
| +2% | +$466K |
|
1809
Empire State Realty Trust
ESRT
$1.34B
| $21.3M | ﹤0.01% |
2,849,332
+44,308
| +2% | +$332K |
|
1810
Stellar Bancorp
STEL
$1.61B
| $21.3M | ﹤0.01% |
930,621
+34,213
| +4% | +$783K |
|
1811
Outset Medical
OM
$243M
| $21.3M | ﹤0.01% |
64,926
+3,553
| +6% | +$1.17M |
|
1812
National Bank Holdings
NBHC
$1.46B
| $21.3M | ﹤0.01% |
732,593
+96,529
| +15% | +$2.8M |
|
1813
First Busey Corp
BUSE
$2.19B
| $21.3M | ﹤0.01% |
1,057,391
+25,460
| +2% | +$512K |
|
1814
AZZ Inc
AZZ
$3.52B
| $21.2M | ﹤0.01% |
487,925
+15,717
| +3% | +$683K |
|
1815
Oscar Health
OSCR
$5B
| $21.2M | ﹤0.01% |
2,628,784
+416,645
| +19% | +$3.36M |
|
1816
Apogee Enterprises
APOG
$903M
| $21.2M | ﹤0.01% |
445,570
+21,098
| +5% | +$1M |
|
1817
CoreCivic
CXW
$2.26B
| $21.1M | ﹤0.01% |
2,240,618
+42,109
| +2% | +$396K |
|
1818
Constellium
CSTM
$2.08B
| $21M | ﹤0.01% |
1,221,311
+43,485
| +4% | +$748K |
|
1819
Sabre
SABR
$738M
| $21M | ﹤0.01% |
6,582,644
+207,935
| +3% | +$663K |
|
1820
Comstock Resources
CRK
$4.67B
| $21M | ﹤0.01% |
1,809,605
+95,841
| +6% | +$1.11M |
|
1821
Recursion Pharmaceuticals
RXRX
$2.11B
| $21M | ﹤0.01% |
2,809,143
+65,659
| +2% | +$490K |
|
1822
Open Lending Corp
LPRO
$252M
| $21M | ﹤0.01% |
1,996,282
-55,035
| -3% | -$578K |
|
1823
Compass
COMP
$4.92B
| $21M | ﹤0.01% |
5,993,648
+782,770
| +15% | +$2.74M |
|
1824
WNS Holdings
WNS
$3.25B
| $21M | ﹤0.01% |
284,239
-457
| -0.2% | -$33.7K |
|
|
CIR
1825
DELISTED
CIRCOR International, Inc
CIR
| $20.9M | ﹤0.01% |
371,016
+6,472
| +2% | +$365K |
|